Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Macular degeneration is a condition that affects the retina, which is neural tissue that lines the back of the eye, like wallpaper in a room. There is an important area ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

The refillable implant is surgically inserted into the eye during a one-time, outpatient procedure. The approval was based on positive one-year results from the phase 3 Pagoda study. In the trial, ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

Laser surgery: Shining a laser light beam ... as well as utilize vision support tools and services. Macular degeneration is a common eye disease, affecting more than 19 million people in the ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

In this Healio Video Perspective from Hawaiian Eye 2025, Richard Small, CEO of Neurotech Pharmaceuticals, discusses the ...

which is also approved for the treatment of wet age-related macular degeneration. “Susvimo presents a unique, convenient treatment alternative to routine eye injections for people with a ...